Franklin Resources Inc Revance Therapeutics, Inc. Transaction History

Franklin Resources Inc

  • $313 Billion
  • Q2 2024

A detailed history of Franklin Resources Inc transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 6,258,918 shares of RVNC stock, worth $16.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,258,918
Previous 6,283,407 0.39%
Holding current value
$16.1 Million
Previous $30.9 Million 47.97%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$2.34 - $4.73 $57,304 - $115,832
-24,489 Reduced 0.39%
6,258,918 $16.1 Million
Q1 2024

May 13, 2024
BUY
$4.65 - $9.31 $7.13 Million - $14.3 Million
1,533,868 Added 32.3%
6,283,407 $30.9 Million
Q4 2023

Feb 09, 2024
BUY
$5.81 - $11.2 $4.14 Million - $7.97 Million
711,978 Added 17.63%
4,749,539 $41.7 Million
Q3 2023

Nov 13, 2023
BUY
$11.47 - $25.07 $20.4 Million - $44.5 Million
1,775,082 Added 78.46%
4,037,561 $46.3 Million
Q2 2023

Aug 11, 2023
SELL
$24.7 - $37.61 $296,696 - $451,771
-12,012 Reduced 0.53%
2,262,479 $57.3 Million
Q1 2023

May 12, 2023
SELL
$18.36 - $35.27 $2.02 Million - $3.88 Million
-110,099 Reduced 4.62%
2,274,491 $73.3 Million
Q4 2022

Feb 10, 2023
SELL
$18.32 - $30.66 $26,160 - $43,782
-1,428 Reduced 0.06%
2,384,590 $44 Million
Q3 2022

Nov 14, 2022
BUY
$14.33 - $28.47 $281,598 - $559,463
19,651 Added 0.83%
2,386,018 $64.4 Million
Q2 2022

Aug 11, 2022
BUY
$11.52 - $20.4 $1.77 Million - $3.13 Million
153,320 Added 6.93%
2,366,367 $32.7 Million
Q1 2022

May 13, 2022
BUY
$12.36 - $20.31 $4.86 Million - $7.98 Million
392,978 Added 21.59%
2,213,047 $43.2 Million
Q4 2021

Feb 11, 2022
SELL
$12.46 - $27.87 $20,060 - $44,870
-1,610 Reduced 0.09%
1,820,069 $29.7 Million
Q3 2021

Nov 12, 2021
SELL
$25.78 - $33.21 $105,388 - $135,762
-4,088 Reduced 0.22%
1,821,679 $50.8 Million
Q2 2021

Aug 13, 2021
BUY
$26.8 - $31.84 $1.85 Million - $2.2 Million
69,157 Added 3.94%
1,825,767 $54.1 Million
Q1 2021

May 13, 2021
BUY
$24.03 - $29.97 $17,950 - $22,387
747 Added 0.04%
1,756,610 $49.1 Million
Q4 2020

Feb 10, 2021
SELL
$23.41 - $28.34 $19.2 Million - $23.3 Million
-822,170 Reduced 31.89%
1,755,863 $49.8 Million
Q3 2020

Nov 12, 2020
SELL
$23.23 - $34.3 $20.6 Million - $30.5 Million
-888,855 Reduced 25.64%
2,578,033 $64.8 Million
Q2 2020

Aug 13, 2020
SELL
$12.6 - $26.55 $2.83 Million - $5.96 Million
-224,600 Reduced 6.08%
3,466,888 $83.3 Million
Q1 2020

May 13, 2020
BUY
$12.46 - $27.81 $1.35 Million - $3.02 Million
108,516 Added 3.03%
3,691,488 $54.6 Million
Q4 2019

Feb 12, 2020
BUY
$11.66 - $20.15 $191,189 - $330,399
16,397 Added 0.46%
3,582,972 $58.2 Million
Q3 2019

Nov 14, 2019
BUY
$10.22 - $14.5 $536,805 - $761,612
52,525 Added 1.49%
3,566,575 $46.4 Million
Q2 2019

Aug 14, 2019
BUY
$10.67 - $15.49 $904,751 - $1.31 Million
84,794 Added 2.47%
3,514,050 $45.6 Million
Q1 2019

May 14, 2019
BUY
$15.4 - $20.39 $6.98 Million - $9.25 Million
453,412 Added 15.24%
3,429,256 $54 Million
Q4 2018

Feb 12, 2019
BUY
$18.06 - $24.96 $7.7 Million - $10.6 Million
426,109 Added 16.71%
2,975,844 $59.9 Million
Q3 2018

Nov 13, 2018
SELL
$23.55 - $30.1 $2.47 Million - $3.15 Million
-104,701 Reduced 3.94%
2,549,735 $63.4 Million
Q2 2018

Aug 14, 2018
SELL
$27.45 - $33.35 $14.2 Million - $17.3 Million
-518,726 Reduced 16.35%
2,654,436 $72.9 Million
Q1 2018

May 10, 2018
SELL
$29.15 - $37.4 $6.44 Million - $8.27 Million
-221,040 Reduced 6.51%
3,173,162 $97.7 Million
Q4 2017

Feb 14, 2018
BUY
$24.55 - $36.3 $2.59 Million - $3.83 Million
105,424 Added 3.21%
3,394,202 $121 Million
Q3 2017

Nov 13, 2017
BUY
$22.55 - $28.1 $74.2 Million - $92.4 Million
3,288,778
3,288,778 $90.6 Million

Others Institutions Holding RVNC

# of Institutions
202
Shares Held
81.8M
Call Options Held
490K
Put Options Held
147K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email